Next Article in Journal
Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomes
Previous Article in Journal
Mafosfamide Boosts GMI-HBVac against HBV via Treg Depletion in HBV-Infected Mice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Exploring the Moderating Effect of Positive and Negative Word-of-Mouth on the Relationship between Health Belief Model and the Willingness to Receive COVID-19 Vaccine

Department of Business Management, National Taipei University of Technology, Taipei 10608, Taiwan
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(6), 1027; https://doi.org/10.3390/vaccines11061027
Submission received: 5 April 2023 / Revised: 8 May 2023 / Accepted: 22 May 2023 / Published: 26 May 2023
(This article belongs to the Section COVID-19 Vaccines and Vaccination)

Abstract

:
This study indicates that the positive and negative effects of word-of-mouth (WOM) have an impact and moderating effect on vaccine uptake willingness, which is important to exploring the factors that affect vaccine uptake. We further analyzed the differences in the impact relationship between variables through questionnaire research. Based on the Health Belief Model (HBM) widely used to explore global health issues, this study focuses on Taiwanese residents and uses a questionnaire survey method. Furthermore, this study investigates the impact of various factors in the HBM on the willingness to receive the COVID-19 vaccine when faced with positive and negative word-of-mouth evaluations from the perspective of vaccine recipients, as well as whether WOM evaluations have an interference effect, along with the differences between variables. Practical recommendations are provided based on the research results, which can serve as a reference for future vaccine promotion programs and health promotion. By improving the national vaccination rate and achieving herd immunity, we aim to increase the persuasiveness of word-of-mouth on public healthcare decision-making. We also hope to provide a basis for health promotion and encourage people to make informed decisions about vaccination.

1. Introduction

Since 2019, the COVID-19 virus has rapidly spread from China to the rest of the world, becoming one of the most widespread pandemics in modern human history. In a short period, the global number of confirmed cases and fatalities grew, making it a leading cause of death. To substantially reduce the risk of severe illness and death, countries relied on vaccine development and the production of oral medications. Vaccination can help alleviate the burden of the disease, reduce pressure on healthcare systems, and prevent outbreaks. Moreover, when a large proportion of a population is immunized, disease transmission is significantly decreased and herd immunity can be achieved [1,2].
Vaccination acts as a protective measure that builds individual’s defenses and disrupts transmission chains. It bolsters the body’s immune system and is the most effective and cost-efficient method to control infectious diseases. Vaccines can successfully prevent severe symptoms after infection, thus reducing hospitalization and death rates [2,3,4]. Numerous past empirical studies have used the Health Belief Model to explore changes in health behaviors during the SARS and H1N1 outbreaks. These studies show that when people are convinced of a pandemic’s severity, they perceive an increased risk of illness, trust the effectiveness of preventive measures, and consider the costs of adopting such behaviors as low, making them more likely to engage in preventive actions [5].
A review of the literature on vaccine acceptance reveals that the “Health Belief Model” has been widely discussed as a theoretical basis for preventive health behaviors since the 1970s. Many researchers have used this theory to study vaccine acceptance in relation to H1N1, measles, human papillomavirus, and rabies vaccines [6,7,8]. Wong [9] applied the Health Belief Model to investigate the acceptance of COVID-19 vaccines among the Hong Kong population, while Ao [10] employed the model to examine the acceptance of COVID-19 vaccines among adults in Lilongwe, Malawi’s capital.
Earlier studies have confirmed that online WOM and recommendations in healthcare impact patients’ medical decisions and the adoption of new medications [11,12]. The research findings mentioned above indicate that prior studies using the Health Belief Model for COVID-19 vaccine-related research have primarily focused on specific populations in certain areas. However, a significant gap exists in the literature regarding the relationship between the Health Belief Model, vaccine acceptance, and positive and negative WOM evaluations.
Although medical word-of-mouth is a common phenomenon, previous studies in both the medical field and vaccine acceptance have rarely addressed the influence of WOM evaluations. Additionally, research has explored patient satisfaction and the effects of service quality, WOM, and trust on satisfaction with medical services [13]. In summary, given the variations in positive and negative WOM evaluations, public perceptions of vaccination may be affected. This study aims to address the knowledge gap in the literature by using positive and negative types of WOM as moderating variables to investigate how positive and negative WOM evaluations may influence people’s health beliefs and vaccine acceptance amid the ongoing COVID-19 pandemic. The goal is to further analyze the differences in the relationships among the various factors.

2. Literature Review

2.1. Health Belief Model, HBM

The Health Belief Model is frequently employed to examine care and medication-taking behaviors among elderly individuals with chronic illnesses, as well as to conduct cross-sectional research on behavioral influences and predictions. It is also utilized in health prevention programs and vaccination research studies. The results indicate that the Health Belief Model can effectively predict and analyze health behaviors.
Perceived susceptibility refers to an individual’s subjective evaluation of the likelihood of getting a disease or confidence in a diagnosis. A stronger perception of susceptibility is linked to a greater health belief and an increased likelihood of engaging in health prevention behaviors. This perception varies among individuals due to differing opinions, resulting in significant differences in vulnerability to a disease. A study by Delshad [14] found that all aspects of the Health Belief Model were associated with epidemic prevention behaviors and predicted these behaviors significantly.
Perceived seriousness refers to an individual’s assessment of the severity of a disease, including the potential harm to their health and social well-being. People’s perceptions of the severity of a disease can differ considerably, and those who underestimate the risk may engage in unhealthy behaviors. This evaluation includes beliefs about the disease and its impact on work and social roles relevant to the individual. Perceived seriousness, along with perceived susceptibility, are cognitive variables that can be influenced by education and knowledge.
Perceived benefits of taking action refer to an individual’s initial assessment of whether a particular action can reduce their susceptibility and severity to a disease while preserving personal health benefits. This belief is influenced by social norms and pressures, which can lead to different actions being embraced. However, the perceived benefits of action may sometimes be influenced by group norms and pressures, as noted by Adams [15].
Perceived barriers to taking action refers to an individual’s assessment of the challenges or obstacles they may face when undertaking a specific action, such as inconvenient transportation, high costs, physical or mental discomfort, unsafe side effects, and negative media coverage. Conflicting information and frequent updates on the COVID-19 situation were perceived as barriers by 65.9% of respondents, according to a study by Jose [16]. Shahnazi [17] highlighted that perceived barriers and self-efficacy were the most significant factors influencing COVID-19 prevention behaviors, with a strong correlation between the two.
Cues to action refer to the motivation or triggers that prompt individuals to take action, which can be internal, such as physical discomfort or symptoms, or external, such as advice from friends and family, social media, healthcare professionals, and health education campaigns. The intensity of the stimulus needed to initiate action depends on the situation. Several studies have investigated factors influencing the intent or behavior of getting vaccinated, including information from healthcare providers and health education, media advocacy, frequent exposure to related information, friends and family suffering from the disease, and individuals with middle to upper socioeconomic status, who are more likely to receive more cues and pay more attention to relevant information.
Self-efficacy refers to an individual’s belief in their ability to perform a specific health behavior in different situations and is part of the Health Belief Model. The stronger a person’s self-efficacy for a particular task, the more confident they are in their ability to complete the task. This confidence leads to a greater willingness to continue participating and putting in more effort to achieve the desired outcome. Many studies have found a significant correlation between self-efficacy and epidemic prevention behaviors, meaning that the higher an individual’s confidence in adopting prevention measures, the more likely they are to engage in such behaviors. Researchers such as Barakat [18], Fathian-Dastgerdi [19], Shahnazi [17], and Koesnoe [20] have demonstrated that higher self-efficacy and perceived benefits of action lead to a greater willingness to engage in epidemic prevention measures.
According to the motivations and literature mentioned earlier, this study derives the following research hypotheses:
H1. 
There will be a significant impact of health beliefs (Perceived susceptibility, Perceived seriousness, Perceived benefits to taking action, Perceived barriers to taking action, Cue to action, and Self-efficacy) on the willingness to receive the COVID-19 vaccine.

2.2. Positive and Negative Word-of-Mouth

The concept of “word-of-mouth” dates back to the 1950s, when it was first discovered and began to be studied academically. Word-of-mouth is an important form of communication that involves the flow of information through interpersonal sources or orally transmitted information. Initially, word-of-mouth refers to the exchange of information through spoken communication between people who are discussing a brand, product, or service without any intention of promoting it commercially. It refers to everyday interactions between people, generating a non-commercial form of communication through natural exchange, and discussing various pieces of information about brands, products, and services. It is also a way for people to understand specific brands, products, and personal ideas through sharing [21,22]. Under high-pressure care situations, consumers will seek information to reduce risk when using medical services. Chang [23] also mentioned that consumers search for product- or service-related information online or offline before making a decision to reduce potential risks [24]. Erkan and Evans [25] found that the adoption of word-of-mouth positively correlates with purchase intention, meaning that as consumers’ willingness to adopt word-of-mouth increases, purchase intention also rises.
Word-of-mouth can be positive or negative and has a significant impact on consumer behavior, affecting purchase decisions and product sales. Positive word-of-mouth is associated with recommendation and persuasion, while negative word-of-mouth is linked to customer complaints and can harm a company’s reputation. Negative word-of-mouth can be damaging as it spreads quickly and may result in decreased consumption and brand attitudes. Therefore, companies should monitor and manage word-of-mouth to ensure positive perceptions of their products or services [26,27].
Based on the aforementioned literature, scholars do not have a consistent conclusion regarding whether positive or negative word-of-mouth has a greater impact, which makes this study even more valuable. According to the motivations and literature mentioned earlier, this study derives the following research hypotheses:
H2. 
Positive word-of-mouth evaluations will have a significant moderating effect on the relationship between health beliefs (Perceived susceptibility, Perceived seriousness, Perceived benefits of taking action, Perceived barriers of taking action, Cue to action, and Self-efficacy) and the willingness to receive the COVID-19 vaccine.
H3. 
Negative word-of-mouth evaluations will have a significant moderating effect on the relationship between health beliefs (Perceived susceptibility, Perceived seriousness, Perceived benefits of taking action, Perceived barriers of taking action, Cue to action, and Self-efficacy) and the willingness to receive the COVID-19 vaccine.

3. Methods

The purpose of this study is to investigate the impact of various variables of the Health Belief Model on the willingness to receive COVID-19 vaccinations, and to examine the effects of positive and negative word-of-mouth as intervening variables. Empirical research is conducted with selected participants who reside in Taiwan and have received COVID-19 vaccinations. The paper concludes with a description of the questionnaire distribution, sample characteristics, and methods of questionnaire content analysis. The conceptual framework is shown in Figure 1:
The nine research variables in this study are measured using the Likert 7-point scale. The questionnaire items are referenced from relevant literature and appropriate scales were selected for each, with the principle of not losing the original intention of the questions, and then making minor adjustments and modifications. SUS references the Walker [28] and Khalafalla [29] studies with four items. SER references the Walker [28] and Jones [30] studies with five items. BEN references the Walker [28] and Berni [31] studies with four items. BAR references the Walker [28] and Berni [31] studies with four items. CUE references the Walker [28] and Khalafalla [29] studies with five items. SEFF references the Yoo [32] and Koesnoe [20] studies with four items. PWOM and NWOM reference the Maisam [33], Popp [34], and An [35] studies with eight items. WRV references the Nga [36] and Ning [37] studies with a total of five items.
In this study, judgmental sampling was used to gather samples. Google online surveys were employed, and six private educational institutions assisted in distributing paper surveys to students and their parents for completion. Further discussions were held regarding survey distribution and collection methods. The survey distribution period lasted from 15 March 2023 to 25 March 2023. Out of the 500 surveys distributed, 433 valid responses were collected after excluding missing responses, blanks, incomplete answers, and invalid multiple selections, resulting in an effective response rate of 86.6%. After collecting the surveys, the study first carried out encoding and data archiving of the questionnaires to facilitate subsequent statistical analysis. SPSS 23.0 statistical software was chosen for data analysis and processing.

4. Results

4.1. Descriptive Statistics Analysis

A descriptive statistical analysis was conducted on various aspects of the questionnaire items, as shown in Table 1, to understand the background information of the research sample. The primary demographic variables analyzed in this section can serve as a foundation for subsequent statistical analyses.

4.2. Factor Analysis and Reliability Analysis

This study employs factor analysis and reliability analysis to evaluate the relevance and consistency of each dimension and item. To enhance rigor, the commonality of each item is extracted if it exceeds 0.5, making it appropriate for analysis. The common factors are obtained using the maximum variance method. When the overall dimensional item Cronbach’s alpha value surpasses 0.7, it indicates consistency, as displayed in Table 2.

4.3. Pearson Correlation Coefficient

In this study, Pearson correlation analysis was used to determine the correlation levels and significance among the variables. The internal consistency of the construct was assessed using the Composite Reliability (CR), with all CR values exceeding 0.8, indicating acceptable convergent validity. The Average Variance Extracted (AVE) was also found to be greater than 0.5, suggesting convergent validity between the latent variables and their respective measurement items. Discriminant validity was evaluated by comparing the square root of AVE to the correlation coefficients between dimensions, which ranged from 0.74 to 0.93, indicating good discriminant validity, as shown in Table 3.

4.4. Variance Analysis

4.4.1. Independent Sample t-Test of Gender

Using an independent sample t-test, the study analyzed gender and each dimension. The study found that there were significant differences between gender and self-awareness of severity (p = 0.004), self-awareness of action benefit (p = 0.043), action cues (p = 0.003), and self-efficacy (p = 0.006) in these four parts. As well, all the average values of males are greater than those of females, as shown in Table 4.

4.4.2. ANOVA of Age

The results of the analysis, as shown in the Table 5, indicate that age has a significant difference in the self-efficacy variable (F = 2.783, p < 0.05). However, there is no difference in the other variables due to different age groups. After post-hoc multiple comparisons, the Scheffe method was used for analysis and it was found that self-efficacy was significantly higher in those under 20 years old than in those between 31 and 40 years old.

4.4.3. ANOVA of Education

According to the analysis results shown in Table 6, there are significant differences in the two variables, action cues (F = 3.059, p < 0.05) and self-efficacy (F = 4.528, p < 0.05), based on the level of education.
Other variables do not vary with differences in education levels. Post-hoc multiple comparisons were conducted using the Scheffe method, revealing that the behavioral cues for individuals with junior high school education are significantly higher than those with high school education. In addition, self-efficacy among individuals with a junior high school education is significantly higher than those with a high school education, and self-efficacy among individuals with a junior high school education is also significantly higher than those with a college education.

4.4.4. ANOVA of Occupation

The results of the analysis, as shown in Table 7, indicate that occupation has a significant difference in the two variables of perceived mobility barriers (F = 2.003, p < 0.05) and PWOM (F = 2.139, p < 0.05). Other variables do not differ due to differences in occupation. The post-hoc multiple comparisons were analyzed using the Scheffe method and it was found that although there was a significant difference, the difference was extremely small, making it impossible to determine the difference.

4.5. Regression Analysis

The relationship between health belief variables and vaccine willingness was analyzed using linear regression, and the results are summarized in Table 8. It shows that perceived susceptibility, perceived severity, perceived benefits of action, perceived barriers to action, cues to action, self-efficacy, and both positive and negative word-of-mouth have a positive impact on COVID-19 vaccination intentions. Therefore, H1 is supported. Additionally, to examine the issue of multicollinearity among the variables, the Tolerance values for each variable are between 0 and 1, and the Variance Inflation Factor (VIF) is less than 2.2, indicating that there is no multicollinearity problem in this study.

4.6. Hierarchical Regression Analysis

This study employs hierarchical regression analysis to examine the impact of PWOM and NWOM on the willingness to receive COVID-19 vaccinations, in relation to six independent variables in the HBM. Furthermore, to avoid multicollinearity issues caused by correlations among the main variables, interaction terms need to be calculated by separately standardizing the independent variables and the moderator variables, and then multiplying them to examine the moderating effects. The results of the SPSS analysis are presented in Table 9, Table 10, Table 11, Table 12, Table 13, Table 14, Table 15, Table 16, Table 17, Table 18, Table 19 and Table 20.
Based on the research method of Aiken & West (1991), this study categorizes PWOM into high and low groups and illustrates the moderating effects, as shown in Figure 2 below.
Based on the research method of Aiken & West (1991), this study categorizes PWOM into high and low groups and illustrates the moderating effects, as shown in Figure 3 below.

5. Conclusions

Previous research on the influence of various independent variables on willingness in health behavior patterns has seldom considered the impact of word-of-mouth reviews. This study reveals that both positive and negative word-of-mouth can have an interference effect, even though some statistical results do not fully support the research hypotheses. Nonetheless, our findings offer an opportunity to investigate topics not covered in past research, aiming to fill the gap in the literature on word-of-mouth. Prior studies have indicated that the influence of positive and negative word-of-mouth information varies, leading to different conclusions. This research discovers that both positive and negative word-of-mouth information have significant interference effects in the dimension of behavioral barriers, with negative word-of-mouth having a more pronounced impact than positive word-of-mouth. This finding aligns with the majority of past research on word-of-mouth effects, which has shown that negative word-of-mouth has a greater influence than positive word-of-mouth in shaping consumer product attitudes or evaluating.
In the ANOVA statistical analysis of this study, it was found that the variables of marital status, residency status, and average monthly income had no significant effect. This study identified significant gender differences in perceived severity, perceived benefits of action, cues to action, and self-efficacy, with males scoring higher averages than females in all four aspects. Age differences revealed significant disparities in self-efficacy, as those aged 20 or younger had considerably higher self-efficacy than those aged 31 to 40. Education level displayed significant differences in cues to action and self-efficacy, with individuals educated up to junior high school having notably higher cues to action than those educated at the high school (vocational) level and higher than those educated at the university (professional) level. Additionally, the study explored the moderating effects of positive and negative word-of-mouth. As shown in Figure 2, under conditions of high positive word-of-mouth, action benefits have a negative impact on the willingness to receive the COVID-19 vaccine; in contrast, when positive word-of-mouth is lower, action benefits have a positive impact on the willingness to receive the COVID-19 vaccine. On the other hand, as can be seen from Figure 3 and Figure 4, regardless of whether positive or negative word-of-mouth is high or low, mobility barriers have a positive impact on the willingness to inject COVID-19 vaccines; in addition, situations with high negative word-of-mouth have a more severe impact.
Compared to the results of previous studies, Tadesse [38] found that factors most closely associated with employees’ preventive behaviors were monthly income, perceived behavioral barriers, cues to action, and self-efficacy. They also discovered that individuals with lower levels of cues to action and self-efficacy were less likely to adopt preventive behaviors. However, some studies have produced different results. For example, Shahnazi [17] found that perceived severity was not significantly related to preventive behavior, while perceived benefits, self-efficacy, behavioral barriers, and cues to action had significant effects. In contrast, Barakat [18] reported that cues to action were not significantly related to preventive behavior. Additionally, Fathian-Dastgerdi [19] found significant negative correlations between adolescents’ perceived susceptibility, behavioral barriers, and preventive behaviors. Shahnazi [17] discovered that while participants had higher perceived susceptibility, severity, benefits, and self-efficacy, their overall preventive behavior was ideal; however, perceived susceptibility and severity were not significantly related to preventive behavior. Furthermore, Alagili [39] found that only perceived susceptibility and severity were not significantly related to preventive behavior.
This study’s practical contributions include investigating the interference effects of positive and negative word-of-mouth reviews, and allowing future epidemic prevention efforts to better understand vaccine recipients’ psychological state after receiving such information. To improve overall epidemic prevention effectiveness, future messages can be promoted through various social media platforms, using vivid descriptions, increasing interactions with consumers, and presenting information through images and videos. Word-of-mouth effects can save costs associated with large-scale vaccine promotion campaigns and help increase vaccination rates more quickly.
However, this study has limitations, such as being cross-sectional, using an online structured questionnaire, and having a limited sample size. Future research should expand the geographical scope, increase the sample size, and consider other variables, such as personal characteristics and organizational culture. Long-term follow-up studies can analyze the public’s changes in vaccine-related knowledge, attitudes, and behavior as the epidemic evolves. Lastly, future research can focus on the influence of social media word-of-mouth on vaccination intentions.

Author Contributions

First draft of the manuscript was written by P.-Y.C.; review and editing, S.-W.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Informed consent was obtained online from all subjects involved in the study before proceeding with the questionnaire.

Data Availability Statement

The datasets generated during the current study are not publicly available but are available from the corresponding author upon reasonable request.

Acknowledgments

The authors gratefully acknowledge the generosity of those who voluntarily responded to the questionnaire of this study.

Conflicts of Interest

The authors declare no conflict of interest.

Autobiography

Dr. Shih-Wei Wu is currently an associate professor in the Department of Business Management at National Taipei University of Technology in Taiwan. He received his PhD from Centre for Risk Research, School of Management, University of Southampton, U.K. in 2008. His present research interests include the following: corporate social responsibility, ESG, corporate fi-nance/governance, and management. Doctoral Candidate Pei-yun Chiang is currently a lecturer and administrator in a private educational institution. Research field in word-of- mouth marketing and consumer behavior issues.

References

  1. Shukla, V.V.; Shah, R.C. Vaccinations in Primary Care. IJP 2018, 85, 1118–1127. [Google Scholar] [CrossRef] [PubMed]
  2. Stern, P.L. Key steps in vaccine development. Ann. Allergy Asthma Immunol. 2020, 125, 17–27. [Google Scholar] [CrossRef] [PubMed]
  3. Abu-Farha, R.; Mukattash, T.; Itani, R.; Karout, S.; Khojah, H.M.J.; Abed Al-Mahmood, A.; Alzoubi, K.H. Willingness of Middle Eastern public to receive COVID-19 vaccines. Saudi Pharm. J. 2021, 29, 734–739. [Google Scholar] [CrossRef] [PubMed]
  4. Gualano, M.R.; Olivero, E.; Voglino, G.; Corezzi, M.; Rossello, P.; Vicentini, C.; Bert, F.; Siliquini, R. Knowledge, attitudes and beliefs towards compulsory vaccination: A systematic review. Hum. Vaccines Immunother. 2019, 15, 918–931. [Google Scholar] [CrossRef] [PubMed]
  5. Duan, T.; Jiang, H.; Deng, X.; Zhang, Q.; Wang, F. Government intervention, risk perception, and the adoption of protective action recommendations: Evidence from the COVID-19 prevention and control experience of China. Int. J. Environ. Res. Public Health 2020, 17, 3387. [Google Scholar] [CrossRef]
  6. Beyene, T.J.; Mindaye, B.; Leta, S.; Cernicchiaro, N.; Revie, C.W. Understanding Factors Influencing Dog Owners’ Intention to Vaccinate Against Rabies Evaluated Using Health Belief Model Constructs. Front. Vet. Sci. 2018, 5, 159. [Google Scholar] [CrossRef]
  7. Donadiki, E.M.; Jiménez-García, R.; Hernández-Barrera, V.; Sourtzi, P.; Carrasco-Garrido, P.; López de Andrés, A.; Jimenez-Trujillo, I.; Velonakis, E.G. Health Belief Model applied to non-compliance with HPV vaccine among female university students. Public Health 2014, 128, 268–273. [Google Scholar] [CrossRef]
  8. Guvenc, G.; Seven, M.; Akyuz, A. Health Belief Model Scale for Human Papilloma Virus and its Vaccination: Adaptation and Psychometric Testing. J. Pediatr Adolesc. Gynecol. 2016, 29, 252–258. [Google Scholar] [CrossRef]
  9. Wong, M.C.S.; Wong, E.L.Y.; Huang, J.; Cheung, A.W.L.; Law, K.; Chong, M.K.C.; Ng, R.W.Y.; Lai, C.K.C.; Boon, S.S.; Lau, J.T.F. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine 2021, 39, 1148–1156. [Google Scholar] [CrossRef]
  10. Ao, Q.; Egolet, R.O.; Yin, H.; Cui, F. Acceptance of COVID-19 Vaccines among Adults in Lilongwe, Malawi: A Cross-Sectional Study Based on the Health Belief Model. Vaccines 2022, 10, 760. [Google Scholar] [CrossRef]
  11. Cao, X.; Liu, Y.; Zhu, Z.; Hu, J.; Chen, X. Online selection of a physician by patients: Empirical study from elaboration likelihood perspective. Comput. Hum. Behav. 2017, 73, 403–412. [Google Scholar] [CrossRef]
  12. Lu, N.; Wu, H. Exploring the impact of word-of-mouth about Physicians’ service quality on patient choice based on online health communities. BMC Med. Inform. Decis. Mak. 2016, 16, 151. [Google Scholar] [CrossRef]
  13. Shabbir, S.; Kaufmann, H.R.; Shehzad, M. Service Quality, Word-of-mouth and Trust: Drivers to Achieve Patient Satisfaction. Sci. Res. Essays 2010, 5, 2457–2462. [Google Scholar]
  14. Delshad Noghabi, A.; Mohammadzadeh, F.; Yoshany, N.; Javanbakht, S. The prevalence of preventive behaviors and associated factors during the early phase of the COVID-19 pandemic among Iranian People: Application of a Health Belief Model. J. Prev. Med. Hyg. 2021, 62, E60–E66. [Google Scholar]
  15. Adams, A.; Hall, M.; Fulghum, J. Utilizing the Health Belief Model to assess vaccine acceptance of patients on hemodialysis. Nephrol. Nurse 2014, 41, 393–408. [Google Scholar]
  16. Jose, R.; Narendran, M.; Bindu, A.; Beevi, N.; Manju, L.; Benny, P.V. Public perception and preparedness for the pandemic COVID 19: A Health Belief Model approach. Clin. Epidemiol. Glob. Health 2021, 9, 41–46. [Google Scholar] [CrossRef]
  17. Shahnazi, H.; Ahmadi-Livani, M.; Pahlavanzadeh, B.; Rajabi, A.; Hamrah, M.S.; Charkazi, A. Assessing preventive health behaviors from COVID-19: A cross sectional study with health belief model in Golestan Province, Northern of Iran. Infect. Dis. Poverty 2020, 9, 157. [Google Scholar] [CrossRef]
  18. Barakat, A.M.; Kasemy, Z.A. Preventive health behaviours during coronavirus disease 2019 pandemic based on health belief model among Egyptians. MECPsych 2020, 27, 43. [Google Scholar] [CrossRef]
  19. Fathian-Dastgerdi, Z.; Khoshgoftar, M.; Tavakoli, B.; Jaleh, M. Factors associated with preventive behaviors of COVID-19 among adolescents: Applying the health belief model. Res. Soc. Adm. Pharm. RSAP 2021, 17, 1786–1790. [Google Scholar] [CrossRef]
  20. Koesnoe, S.; Siddiq, T.H.; Pelupessy, D.C.; Yunihastuti, E.; Awanis, G.S.; Widhani, A.; Karjadi, T.H.; Maria, S.; Hasibuan, A.S.; Rengganis, I. Using Integrative Behavior Model to Predict COVID-19 Vaccination Intention among Health Care Workers in Indonesia: A Nationwide Survey. Vaccines 2022, 10, 719. [Google Scholar] [CrossRef]
  21. Liu, F.; Liu, Y.L.; Hung, Y.L.; Lee, M.J. Ecotorism travel risk word-of-mouth: Via fuzzy set perspective. IJDHCIM 2015, 3, 21–30. [Google Scholar]
  22. Shin, J.; Chae, H.; Ko, E. The power of e-WOM using the hashtag: Focusing on SNS advertising of SPA brands. Int. J. Advert. 2018, 37, 71–85. [Google Scholar] [CrossRef]
  23. Chang, H.H.; Wu, L.H. An Examination of Negative E-WOM Adoption: Brand Commitment as A Moderator. Decis. Support Syst. 2014, 59, 206–218. [Google Scholar] [CrossRef]
  24. Verma, S.; Yadav, N. Past, present, and future of electronic word-of-mouth (EWOM). J. Interact. Mark. 2021, 53, 111–128. [Google Scholar] [CrossRef]
  25. Erkan, I.; Evans, C. The influence of eWOM in social media on consumers’ purchase intentions: An extended approach to information adoption. Comput. Hum. Behav. 2016, 61, 47–55. [Google Scholar] [CrossRef]
  26. Bakar, M.S.; Hidayati, N.; Giffani, I.R. Apology and Compensation Strategy on Customer Forgiveness and Negative Word-of-mouth. J. Manaj. Kewirausahaan 2019, 21, 41–50. [Google Scholar] [CrossRef]
  27. Rosario, A.B.; Sotgiu, F.; De Valck, K.; Bijmolt, T.H.A. The effect of electronic word-of-mouth on sales: A meta-analytic review of platform, product, and metric factors. J. Mark. Res. 2016, 53, 297–318. [Google Scholar] [CrossRef]
  28. Walker, A.N.; Zhang, T.; Peng, X.Q.; Ge, J.J.; Gu, H.; You, H. Vaccine Acceptance and Its Influencing Factors: An Online Cross-Sectional Study among International College Students Studying in China. Vaccines 2021, 9, 585. [Google Scholar] [CrossRef]
  29. Khalafalla, H.E.; Tumambeng, M.Z.; Halawi, M.H.A.; Masmali, E.M.A.; Tashari, T.B.M.; Arishi, F.H.A.; Shadad, R.H.M.; Alfaraj, S.Z.A.; Fathi, S.M.A.; Mahfouz, M.S. COVID-19 Vaccine Hesitancy Prevalence and Predictors among the Students of Jazan University, Saudi Arabia Using the Health Belief Model: A Cross-Sectional Study. Vaccines 2022, 10, 289. [Google Scholar] [CrossRef]
  30. Jones, A.; Wallis, D. Using the Health Belief Model to Identify Predictors of COVID-19 Vaccine Acceptance among a Sample of Pregnant Women in the U.S.: A Cross-Sectional Survey. Vaccines 2022, 10, 842. [Google Scholar] [CrossRef]
  31. Berni, I.; Menouni, A.; Filali Zegzouti, Y.; Kestemont, M.-P.; Godderis, L.; El Jaafari, S. Factors Associated with COVID-19 Vaccine Acceptance in Morocco: Applying the Health Belief Model. Vaccines 2022, 10, 784. [Google Scholar] [CrossRef]
  32. Yoo, H.J.; Song, E. Effects of Personal Hygiene Habits on Self-Efficacy for Preventing Infection, Infection-Preventing Hygiene Behaviors, and Product-Purchasing Behaviors. Sustainability 2021, 13, 9483. [Google Scholar] [CrossRef]
  33. Maisam, S.; Mahsa, R.-d. Positive word of mouth marketing: Explaining the roles of value congruity and brand love. J. Compet. 2016, 8, 19–37. [Google Scholar]
  34. Popp, B.; Woratschek, H. Consumer–brand identification revisited: An integrative framework of brand identification, customer satisfaction, and price image and their role for brand loyalty and word of mouth. J. Brand Manag. 2017, 24, 250–270. [Google Scholar] [CrossRef]
  35. An, J.; Do, D.K.X.; Ngo, L.V.; Quan, T.H.M. Turning brand credibility into positive word-of-mouth: Integrating the signaling and social identity perspectives. J. Brand Manag. 2019, 26, 157–175. [Google Scholar] [CrossRef]
  36. Nga, N.T.V.; Xuan, V.N.; Trong, V.A.; Thao, P.H.; Doanh, D.C. Perceived Barriers and Intentions to Receive COVID-19 Vaccines: Psychological Distress as a Moderator. Vaccines 2023, 11, 289. [Google Scholar] [CrossRef]
  37. Ning, C.; Guo, D.; Wu, J.; Gao, H. Media Exposure and Media Credibility Influencing Public Intentions for Influenza Vaccination. Vaccines 2022, 10, 526. [Google Scholar] [CrossRef]
  38. Tadesse, T.; Alemu, T.; Amogne, G.; Endazenaw, G.; Mamo, E. Predictors of Coronavirus Disease 2019 (COVID-19) Prevention Practices Using Health Belief Model Among Employees in Addis Ababa, Ethiopia, 2020. Infect. Drug Resist. 2020, 13, 3751–3761. [Google Scholar] [CrossRef]
  39. Alagili, D.E.; Bamashmous, M. The Health Belief Model as an explanatory framework for COVID-19 prevention practices. J. Infect. Public Health 2021, 14, 1398–1403. [Google Scholar] [CrossRef]
Figure 1. Conceptual framework for the hypothesized predictors of the willingness to receive a COVID-19 vaccine.
Figure 1. Conceptual framework for the hypothesized predictors of the willingness to receive a COVID-19 vaccine.
Vaccines 11 01027 g001
Figure 2. The interference effect of PWOM on the relationship between perceived benefits and willingness to receive COVID-19 vaccine.
Figure 2. The interference effect of PWOM on the relationship between perceived benefits and willingness to receive COVID-19 vaccine.
Vaccines 11 01027 g002
Figure 3. The interference effect of PWOM on the relationship between behavioral benefits and willingness to receive vaccine.
Figure 3. The interference effect of PWOM on the relationship between behavioral benefits and willingness to receive vaccine.
Vaccines 11 01027 g003
Figure 4. The interference effect of NWOM on the relationship between perceived barriers to action and willingness to receive vaccine.
Figure 4. The interference effect of NWOM on the relationship between perceived barriers to action and willingness to receive vaccine.
Vaccines 11 01027 g004
Table 1. Demographic characteristics of the respondents (n = 433).
Table 1. Demographic characteristics of the respondents (n = 433).
VariablesCharacteristicsFrequencyPercentage
COVID-19
Vaccinations
one vaccine dose194.4
two vaccine doses8720.1
three vaccine doses or more31071.6
Never173.9
Confirmed COVID-19Yes24055.4
No19344.6
GenderMale19645.3
Female23754.7
Age<20163.7
21–309722.4
31–4013030.0
41–5010824.9
51–60399.0
>61439.9
Marital StatusMarried25158.0
Single14533.5
Divorced317.2
Widowed61.4
EducationMiddle school and below163.7
High school8519.6
Associate or bachelor23153.3
Master and above10123.3
Current Living StatusLiving alone5212.0%
Live with spouse8619.9%
Live with parents or children27563.5%
Others74.6%
OccupationStudents235.3%
Civil servant337.6%
Business6815.7%
Workers255.8%
Manufacturing7617.6%
Agriculture, forestry, fishery and animal husbandry71.6%
Service industry11927.5%
Freelancer4410.2%
Others388.8%
Average Monthly Income (TWD)<20,000317.2
20,001–35,0006515.0
35,001–50,00018442.5
50,001–65,0008820.3
65,001–85,000255.8
85,001–100,000173.9
>100,000235.3
Table 2. Factor Analysis and Reliability Analysis of Each Variable.
Table 2. Factor Analysis and Reliability Analysis of Each Variable.
FactorsItemsFactor LoadingsCommunalityExplained Variation (%)Cronbach’s α
SUS10.6420.82282.720.724
20.7550.768
30.8190.854
40.7780.864
SER10.7080.50157.080.810
20.8040.646
30.7820.612
40.7480.560
50.7320.536
BEN10.9200.84681.080.883
20.9320.868
30.8480.719
BAR10.8200.67372.330.872
20.8680.754
30.8630.745
40.8490.721
CUE10.7430.55360.410.835
20.7610.580
30.8300.688
40.8260.682
50.7200.518
SEFF10.7810.61055.700.730
20.7970.636
30.7070.500
40.6950.483
WRV10.7700.59470.920.861
20.8910.793
30.8680.754
40.8340.696
PWOM10.8160.66671.070.862
20.8900.791
30.8800.774
40.7820.611
NWOM10.9290.86486.200.964
20.9210.848
30.9250.856
40.9380.880
Table 3. Pearson Correlation Analysis of Each Variable.
Table 3. Pearson Correlation Analysis of Each Variable.
SUSSERBENBARCUESEFFWRVPWOMNWOMCRAVE
SUS0.750.615 **0.133 **0.379 **0.274 **0.319 **0.191 **0.250 **0.194 **0.840.56
SER 0.750.223 **0.409 **0.501 **0.502 **0.271 **0.375 **0.214 **0.870.57
BEN 0.900.387 **0.365 **0.244 **0.626 **0.401 **0.149 **0.930.81
BAR 0.850.219 **0.217 **0.352 **0.158 **0.435 **0.910.72
CUE 0.770.657 **0.494 **0.561 **0.227 **0.880.60
SEFF 0.740.436 **0.472 **0.284 **0.830.55
WRV 0.840.590 **0.175 **0.910.71
PWOM 0.840.243 **0.910.71
NWOM 0.930.960.86
** The correlation is significant at the 0.01 level (two-tailed). The diagonal values are the square root of the AVE values, and the upper triangle is the Pearson correlation coefficient.
Table 4. Independent Sample t-test of Gender Variable.
Table 4. Independent Sample t-test of Gender Variable.
VariablesGenderMeanStandard DeviationtSig.
SUSMale5.5640.888−0.3340.738
Female5.5900.723
SERMale5.7790.7842.8760.004 *
Female5.5670.743
BENMale5.9150.8622.0260.043 *
Female5.7400.922
BARMale5.4781.062−0.3390.734
Female5.5110.879
CUEMale5.6940.7202.9910.003 *
Female5.4900.698
SEFFMale5.7620.6852.7540.006 **
Female5.5800.679
WRVMale5.7680.8050.5300.596
Female5.7270.800
PWOMMale5.7920.8541.9640.050
Female5.6390.744
NWOMMale5.21941.20030−0.1550.877
Female5.23631.06294
* p < 0.05; ** p < 0.01.
Table 5. One-Way ANOVA Table of Age Variable.
Table 5. One-Way ANOVA Table of Age Variable.
VariablesAgeMeanStandard DeviationFp
SUS<205.691.070.8310.528
21–305.640.84
31–405.510.73
41–505.590.84
51–605.420.77
>615.700.73
SER<206.060.801.3890.227
21–305.670.77
31–405.640.73
41–505.640.83
51–605.490.71
>615.740.72
BEN<206.150.761.6030.158
21–305.751.00
31–405.810.84
41–505.750.89
51–605.780.97
>616.110.81
BAR<205.421.330.5320.752
21–305.401.09
31–405.550.85
41–505.440.90
51–605.600.96
>615.611.02
CUE<206.030.741.9000.093
21–305.580.77
31–405.530.68
41–505.550.67
51–605.510.69
>615.730.76
SEFF<206.200.672.7830.017 *
21–305.640.73
31–405.600.65
41–505.670.63
51–605.540.64
>615.780.79
WRV<205.970.851.4610.202
21–305.770.87
31–405.690.73
41–505.660.74
51–605.710.94
>615.990.82
PWOM<206.090.971.2310.294
21–305.760.83
31–405.710.76
41–505.610.79
51–605.610.68
>615.740.891
NWOM<205.421.391.5660.168
21–305.291.27
31–405.381.00
41–505.101.05
51–604.911.08
>615.151.23
* p < 0.05.
Table 6. One-Way ANOVA Table of Education Level Variable.
Table 6. One-Way ANOVA Table of Education Level Variable.
VariablesEducationMeanStandard DeviationFp
SUSMiddle school and below5.690.920.4120.744
High school5.540.78
Associate or bachelor5.560.81
Master and above5.640.78
SERMiddle school and below6.040.752.2230.085
High school5.580.78
Associate or bachelor5.630.76
Master and above5.750.76
BENMiddle school and below5.960.920.2990.826
High school5.840.85
Associate or bachelor5.830.89
Master and above5.760.95
BARMiddle school and below5.581.060.7540.520
High school5.630.82
Associate or bachelor5.450.97
Master and above5.471.05
CUEMiddle school and below6.050.693.0590.028 *
High school5.470.76
Associate or bachelor5.590.69
Master and above5.590.72
SEFFMiddle school and below6.130.714.5280.004 *
High school5.550.71
Associate or bachelor5.620.67
Master and above5.780.67
WRVMiddle school and below5.801.000.5250.666
High school5.690.72
Associate or bachelor5.730.83
Master and above5.820.76
PWOMMiddle school and below6.001.084.4550.004 *
High school5.440.74
Associate or bachelor5.770.77
Master and above5.740.82
NWOMMiddle school and below5.281.430.3910.759
High school5.211.00
Associate or bachelor5.271.09
Master and above5.131.27
* p < 0.05.
Table 7. One-Way ANOVA Table of Occupation Variable.
Table 7. One-Way ANOVA Table of Occupation Variable.
VariablesOccupationMeanStandard DeviationFp
SUSStudents5.481.120.5290.835
Civil servant5.600.79
Business5.530.67
Workers5.650.85
Manufacturing5.560.70
Agriculture, forestry, fishery and animal husbandry5.960.99
Service industry5.640.80
Freelancer5.450.89
Others5.590.86
SERStudents5.830.771.1790.310
Civil servant5.780.75
Business5.660.68
Workers5.820.83
Manufacturing5.640.76
Agriculture, forestry, fishery and animal husbandry6.230.75
Service industry5.640.81
Freelancer5.500.76
Others5.560.78
BENStudents5.971.041.2760.254
Civil servant5.990.87
Business5.950.92
Workers5.910.79
Manufacturing5.701.02
Agriculture, forestry, fishery and animal husbandry6.191.00
Service industry5.840.83
Freelancer5.570.72
Others5.690.94
BARStudents5.251.362.0030.045 *
Civil servant5.740.87
Business5.660.82
Workers5.710.77
Manufacturing5.590.81
Agriculture, forestry, fishery and animal husbandry6.071.02
Service industry5.321.13
Freelancer5.460.82
Others5.310.91
CUEStudents5.690.940.7510.647
Civil servant5.610.72
Business5.550.68
Workers5.510.71
Manufacturing5.540.69
Agriculture, forestry, fishery and animal husbandry6.060.95
Service industry5.620.72
Freelancer5.460.62
Others5.620.74
SEFFStudents5.870.781.3290.227
Civil servant5.770.80
Business5.630.57
Workers5.500.67
Manufacturing5.660.68
Agriculture, forestry, fishery and animal husbandry6.250.82
Service industry5.660.68
Freelancer5.570.68
Others5.610.71
WRVStudents5.880.840.9360.486
Civil servant5.850.77
Business5.770.90
Workers5.470.69
Manufacturing5.730.74
Agriculture, forestry, fishery and animal husbandry6.210.87
Service industry5.770.83
Freelancer5.660.76
Others5.680.75
PWOMStudents6.020.942.1390.031 *
Civil servant5.860.84
Business5.830.71
Workers5.530.87
Manufacturing5.570.76
Agriculture, forestry, fishery and animal husbandry6.180.79
Service industry5.750.77
Freelancer5.550.72
Others5.510.92
NWOMStudents4.901.671.0820.374
Civil servant5.471.04
Business5.261.13
Workers5.280.97
Manufacturing5.380.90
Agriculture, forestry, fishery and animal husbandry5.821.21
Service industry5.101.25
Freelancer5.220.84
Others5.141.13
* p < 0.05.
Table 8. Regression Analysis of Independent Variables on Dependent Variables.
Table 8. Regression Analysis of Independent Variables on Dependent Variables.
Regression AnalysisßR2Adj R2tFp
SUS→WRV0.1470.0220.0203.45311.9240.001 **
SER→WRV0.1990.0400.0384.70522.1390.000 ***
BEN→WRV0.3370.1140.1128.30769.0130.000 ***
BAR→WRV0.3960.1570.15510.010100.2020.000 ***
CUE→WRV0.3280.1080.1068.05964.9490.000 ***
SEFF→WRV0.3030.0920.0907.38354.5040.000 ***
PWOM→WRV0.4100.1680.16710.439108.9800.000 ***
NWOM→WRV0.2220.0490.0485.28627.9390.000 ***
** p < 0.01; *** p < 0.001.
Table 9. The Moderate Effect of PWOM between Perceived Susceptibility and Willingness to Receive COVID-19 Vaccine.
Table 9. The Moderate Effect of PWOM between Perceived Susceptibility and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
SUS0.1914.0380.0471.1610.0441.082
PWOM--0.57814.4010.57714.324
SUS × NWOM--0.0200.499
F16.302115.75577.119
R20.0360.3500.350
ΔR20.0360.3140.000
Result: PWOM has no moderate effect between Perceived Susceptibility and Willingness to Receive COVID-19 Vaccine. (p = 0.618 > 0.05)
Table 10. The Moderate Effect of PWOM between Perceived Seriousness and Willingness to Receive COVID-19 Vaccine.
Table 10. The Moderate Effect of PWOM between Perceived Seriousness and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
SER0.2710.58380.0581.3740.0581.390
PWOM--0.56813.5570.56613.432
SER × NWOM--0.0210.538
F34.086116.17077.415
R20.0730.3510.351
ΔR20.0730.2770.000
Result: PWOM has no moderate effect between the Perceived Seriousness and Willingness to Receive COVID-19 Vaccine. (p = 0.591 > 0.05)
Table 11. The Moderate Effect of PWOM between Perceived Benefits of Taking Action and Willingness to Receive COVID-19 Vaccine.
Table 11. The Moderate Effect of PWOM between Perceived Benefits of Taking Action and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
BEN0.62616.6860.46512.8690.44112.009
PWOM--0.40411.1780.41011.439
BEN × NWOM--−0.098−2.901
F278.407241.709166.722
R20.3920.5290.538
ΔR20.3920.1370.009
Result: PWOM has a moderate effect between the Perceived Benefits of Taking Action and Willingness to Receive COVID-19 Vaccine. (p = 0.004 < 0.05)
Table 12. The Moderate Effect of PWOM between Perceived Barriers of Taking Action and and Willingness to Receive COVID-19 Vaccine.
Table 12. The Moderate Effect of PWOM between Perceived Barriers of Taking Action and and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
BAR0.3527.7960.2657.0960.2867.471
PWOM--0.54814.6840.54514.659
BAR × NWOM--−0.086−2.273
F60.784153.335104.937
R20.1240.4160.423
ΔR20.1240.2930.007
Result: PWOM has no moderate effect between Perceived Barriers to Taking Action and Willingness to Receive COVID-19 Vaccine. (p = 0.023 < 0.05)
Table 13. The Moderate Effect of PWOM between Cues to Action and Willingness to Receive COVID-19 Vaccine.
Table 13. The Moderate Effect of PWOM between Cues to Action and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
CUE0.49411.7890.2385.2040.2405.246
PWOM--0.45710.0030.45810.020
CUE × NWOM--−0.030−0.776
F138.990135.49290.445
R20.2440.3870.387
ΔR20.2440.1430.001
Result: PWOM has no moderate effect between Cues to Action and Willingness to Receive COVID-19 Vaccine. (p = 0.438 > 0.05)
Table 14. The Moderate Effect of PWOM between Self-Efficacy and Willingness to Receive COVID-19 Vaccine.
Table 14. The Moderate Effect of PWOM between Self-Efficacy and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
SEFF0.43610.0580.2034.7000.2024.687
PWOM--0.49411.4680.49411.437
SEFF × NWOM--−0.001−0.032
F101.166131.66287.571
R20.1900.3800.380
ΔR20.1900.1900.000
Result: PWOM has no moderate effect between Self-Efficacy and Willingness to Receive COVID-19 Vaccine. (p = 0.975 > 0.05)
Table 15. The Moderate Effect of NWOM between Perceived Susceptibility and Willingness to Receive COVID-19 Vaccine.
Table 15. The Moderate Effect of NWOM between Perceived Susceptibility and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
SUS0.1914.0380.1633.4150.1723.582
NWOM--0.1433.0040.1412.946
SUS × NWOM--0.0741.581
F16.30212.8139.405
R20.0360.0560.062
ΔR20.0360.0200.005
Result: NWOM has no moderate effect between Perceived Susceptibility and Willingness to Receive COVID-19 Vaccine. (p = 0.115 > 0.05)
Table 16. The Moderate Effect of NWOM between Perceived Seriousness and Willingness to Receive COVID-19 Vaccine.
Table 16. The Moderate Effect of NWOM between Perceived Seriousness and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
SER0.2715.8380.2445.1850.2495.175
NWOM--0.1232.6050.1172.379
SER × NWOM--0.0230.474
F34.08620.66413.826
R20.0730.0880.088
ΔR20.0730.0140.000
Result: NWOM has no moderate effect between Perceived Seriousness and Willingness to Receive COVID-19 Vaccine. (p = 0.636 > 0.05)
Table 17. The Moderate Effect of NWOM between Perceived Benefits of Taking Action and and Willingness to Receive COVID-19 Vaccine.
Table 17. The Moderate Effect of NWOM between Perceived Benefits of Taking Action and and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
BEN0.62616.6860.61416.2440.61016.041
NWOM--0.0842.2100.0802.104
BEN × NWOM--0.0310.820
F278.407142.90195.419
R20.3920.3990.400
ΔR20.3920.0070.001
Result: NWOM has a moderate effect between Perceived Benefits of Taking Action and Willingness to Receive COVID-19 Vaccine. (p = 0.413 > 0.05)
Table 18. The Moderate Effect of NWOM between Perceived Barriers of Taking Action and Willingness to Receive COVID-19 Vaccine.
Table 18. The Moderate Effect of NWOM between Perceived Barriers of Taking Action and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
BAR0.3527.7960.3406.7780.4038.294
NWOM--0.0270.5440.0881.815
BAR × NWOM--0.3116.832
F60.78430.49038.044
R20.1240.1240.210
ΔR20.1240.0010.086
Result: NWOM has a moderate effect between Perceived Barriers to Taking Action and Willingness to Receive COVID-19 Vaccine. (p = 0.000 < 0.05)
Table 19. The Moderate Effect of NWOM between Cues to Action and Willingness to Receive COVID-19 Vaccine.
Table 19. The Moderate Effect of NWOM between Cues to Action and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
CUE0.49411.7890.47911.1490.47611.057
NWOM--0.0661.5430.0841.734
CUE × NWOM--−0.037−0.793
F138.99070.90747.440
R20.2440.2480.249
ΔR20.2440.0040.001
Result: NWOM has no moderate effect between Cues to Action and Willingness to Receive COVID-19 Vaccine. (p = 0.428 > 0.05)
Table 20. The Moderate Effect of NWOM between Self-Efficacy and Willingness to Receive COVID-19 Vaccine.
Table 20. The Moderate Effect of NWOM between Self-Efficacy and Willingness to Receive COVID-19 Vaccine.
Hierarchical RegressionDependent Variable: Willingness to Receive the COVID-19 Vaccine
Model 1Model 2Model 3
ßtßtßt
SEFF0.43610.0580.4209.2990.4199.213
NWOM--0.0561.2300.0591.200
SEFF × NWOM--−0.008−0.171
F101.16651.40034.199
R20.1900.1930.193
ΔR20.1900.0030.000
Result: NWOM has no moderate effect between Self-Efficacy and Willingness to Receive COVID-19 Vaccine. (p = 0.864 > 0.05)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wu, S.-W.; Chiang, P.-Y. Exploring the Moderating Effect of Positive and Negative Word-of-Mouth on the Relationship between Health Belief Model and the Willingness to Receive COVID-19 Vaccine. Vaccines 2023, 11, 1027. https://doi.org/10.3390/vaccines11061027

AMA Style

Wu S-W, Chiang P-Y. Exploring the Moderating Effect of Positive and Negative Word-of-Mouth on the Relationship between Health Belief Model and the Willingness to Receive COVID-19 Vaccine. Vaccines. 2023; 11(6):1027. https://doi.org/10.3390/vaccines11061027

Chicago/Turabian Style

Wu, Shih-Wei, and Pei-Yun Chiang. 2023. "Exploring the Moderating Effect of Positive and Negative Word-of-Mouth on the Relationship between Health Belief Model and the Willingness to Receive COVID-19 Vaccine" Vaccines 11, no. 6: 1027. https://doi.org/10.3390/vaccines11061027

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop